Skip to content
Screener

Celcuity CELC Debt-to-equity

Debt-to-equity at other companies

Eli Lilly logo
Eli LillyLLY
1.6×-0.6×
Gilead Sciences logo
Gilead SciencesGILD
2.2×+1.0×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
0.0×
Immunome logo
ImmunomeIMNM
0.0×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
0.0×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
0.0×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.55B+150%
Enterprise value$4.54B+142%

Returns & leverage

See full
Return on equity-275.2%-990pp
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on the most recent quarter.

The source filing: Celcuity’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 5:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023180

FAQ

What is Celcuity's debt-to-equity?
Celcuity (CELC) reported debt-to-equity of 2.6× in Q1 2026.
How has Celcuity's debt-to-equity changed year-over-year?
Celcuity's debt-to-equity increased by 111.6% year-over-year, from 1.2× to 2.6×.
What is the long-term trend for Celcuity's debt-to-equity?
Over 5 years (2020 to 2025), Celcuity's debt-to-equity has grown at a 120.4% compound annual growth rate (CAGR), from 0× to 1.4×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Ask your AI about Celcuity's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude